Plus Therapeutics (PSTV) Competitors $0.30 -0.01 (-3.65%) Closing price 07/3/2025 03:59 PM EasternExtended Trading$0.30 +0.00 (+0.34%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PSTV vs. EDAP, HYPR, ICCM, CTCX, MDAI, APT, MLSS, DXR, NEPH, and SPAIShould you be buying Plus Therapeutics stock or one of its competitors? The main competitors of Plus Therapeutics include EDAP TMS (EDAP), Hyperfine (HYPR), IceCure Medical (ICCM), Carmell (CTCX), Spectral AI (MDAI), Alpha Pro Tech (APT), Milestone Scientific (MLSS), Daxor (DXR), Nephros (NEPH), and Safe Pro Group (SPAI). These companies are all part of the "medical equipment" industry. Plus Therapeutics vs. Its Competitors EDAP TMS Hyperfine IceCure Medical Carmell Spectral AI Alpha Pro Tech Milestone Scientific Daxor Nephros Safe Pro Group EDAP TMS (NASDAQ:EDAP) and Plus Therapeutics (NASDAQ:PSTV) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment. Which has better earnings and valuation, EDAP or PSTV? Plus Therapeutics has lower revenue, but higher earnings than EDAP TMS. EDAP TMS is trading at a lower price-to-earnings ratio than Plus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEDAP TMS$69.18M0.86-$20.58M-$0.62-2.57Plus Therapeutics$5.82M2.59-$12.98M-$2.94-0.10 Does the media favor EDAP or PSTV? In the previous week, EDAP TMS and EDAP TMS both had 2 articles in the media. EDAP TMS's average media sentiment score of 0.00 equaled Plus Therapeutics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EDAP TMS 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Plus Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate EDAP or PSTV? EDAP TMS presently has a consensus price target of $8.50, indicating a potential upside of 432.92%. Plus Therapeutics has a consensus price target of $10.83, indicating a potential upside of 3,559.91%. Given Plus Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Plus Therapeutics is more favorable than EDAP TMS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EDAP TMS 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Plus Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is EDAP or PSTV more profitable? EDAP TMS has a net margin of -34.45% compared to Plus Therapeutics' net margin of -520.90%. Plus Therapeutics' return on equity of 0.00% beat EDAP TMS's return on equity.Company Net Margins Return on Equity Return on Assets EDAP TMS-34.45% -51.42% -26.43% Plus Therapeutics -520.90%N/A -202.73% Do insiders & institutionals believe in EDAP or PSTV? 62.7% of EDAP TMS shares are owned by institutional investors. Comparatively, 3.3% of Plus Therapeutics shares are owned by institutional investors. 0.2% of EDAP TMS shares are owned by company insiders. Comparatively, 5.5% of Plus Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryPlus Therapeutics beats EDAP TMS on 8 of the 13 factors compared between the two stocks. Get Plus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PSTV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PSTV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PSTV vs. The Competition Export to ExcelMetricPlus TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.10M$2.43B$5.56B$9.04BDividend YieldN/A1.78%5.22%3.99%P/E Ratio-0.109.0227.6520.23Price / Sales2.59680.43419.56119.26Price / CashN/A21.7726.2128.59Price / Book-0.194.558.035.65Net Income-$12.98M$31.26M$3.18B$249.15M7 Day Performance-14.89%2.98%2.88%2.91%1 Month Performance-9.06%3.46%1.67%4.11%1 Year Performance-80.90%0.77%34.39%20.98% Plus Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PSTVPlus Therapeutics1.4171 of 5 stars$0.30-3.6%$10.83+3,559.9%-80.9%$15.10M$5.82M-0.1020EDAPEDAP TMS2.3701 of 5 stars$1.65-1.2%$8.50+415.2%-69.0%$62.44M$69.18M-2.66230HYPRHyperfine1.8641 of 5 stars$0.72-3.0%$1.06+47.3%-21.1%$57.72M$12.89M-1.33190ICCMIceCure Medical2.0921 of 5 stars$1.00-1.4%$2.50+151.1%+45.1%$56.06M$3.29M-3.5660News CoverageCTCXCarmellN/A$2.59-0.8%N/A+46.1%$54.14M$32.84K0.0014News CoverageMDAISpectral AI2.9736 of 5 stars$2.48+17.0%$4.75+91.5%+40.9%$53.67M$29.58M-4.5983News CoverageAnalyst RevisionHigh Trading VolumeAPTAlpha Pro Tech1.5038 of 5 stars$4.69-0.8%N/A-17.0%$50.95M$58.18M12.68120MLSSMilestone Scientific2.8871 of 5 stars$0.64-12.4%$1.25+96.4%+1.5%$49.95M$8.61M-9.0930Negative NewsGap UpDXRDaxorN/A$9.79+7.0%$25.00+155.4%+15.6%$44.26MN/A0.0037Gap UpNEPHNephros0.8514 of 5 stars$4.09+6.0%$5.00+22.2%+96.2%$40.92M$14.16M58.4430Positive NewsHigh Trading VolumeSPAISafe Pro GroupN/A$2.75+3.0%N/AN/A$40.51M$2.17M-3.4011 Related Companies and Tools Related Companies EDAP TMS Competitors Hyperfine Competitors IceCure Medical Competitors Carmell Competitors Spectral AI Competitors Alpha Pro Tech Competitors Milestone Scientific Competitors Daxor Competitors Nephros Competitors Safe Pro Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PSTV) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSTV Stock Alerts